FDA requires new labels on popular antibiotic after Channel 2 investigation
The Food and Drug Administration is warning doctors that the drugs exposed in a 2015 Channel 2 consumer investigation are too risky for many common infections.
The agency will require new labels on fluoroquinolone antibiotics, including the drug levofloxacin.
Related Headlines
"For somebody else not to have to go through what I went through, that would be great," said Jeff Stephens, of Villa Rica.
Side effects from seven pills of the medication left Stephens permanently disabled. It severely damaged his nervous system and put him in a wheelchair. He'd been prescribed the drug for a sinus infection.
The FDA warning said for routine ailments like sinus infections, bronchitis, and common urinary tract infections, the risks outweigh the benefits.
No comments:
Post a Comment